Page last updated: 2024-12-07

nitrosonium ion

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

The nitrosonium ion (NO+) is a highly reactive cation that plays a significant role in various chemical processes. It is a strong electrophile, readily reacting with nucleophiles. The ion can be generated in situ through the oxidation of nitric oxide (NO) or by protonation of nitrous oxide (N2O). Nitrosonium ions are involved in nitrosation reactions, a process that involves the introduction of a nitro group (NO2) into a molecule. This process has implications in various fields, including organic synthesis, biochemistry, and atmospheric chemistry. For example, nitrosonium ions are implicated in the formation of nitrosamines, which are known carcinogens. The study of nitrosonium ions is crucial for understanding the mechanisms of these reactions and for developing strategies to control their formation and reactivity. Nitrosonium ions are also involved in the formation of nitroso compounds, which are important intermediates in various industrial processes. Their reactivity makes them useful reagents in organic synthesis and for probing the mechanisms of chemical reactions.'

nitrosonium ion: a nitric oxide congener [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

oxidonitrogen(1+) : A monovalent inorganic cation resulting from the removal of the unpaired electron from nitric oxide. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID84878
CHEBI ID29120
MeSH IDM0489877

Synonyms (16)

Synonym
oxidonitrogen(1+)
[no](+)
oxidonitrogen(+)
nitrosonium
nitrilooxonium
no(+)
CHEBI:29120
nitric oxide(1+)
nitrogen oxide cation
nitrosonium ion
no+
nitrosyl ion
azanylidyneoxidanium
KEJOCWOXCDWNID-UHFFFAOYSA-N
Q2500533
DTXSID901027026
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
nitrogen oxide
monovalent inorganic cationAn atom or small molecule with a positive charge that does not contain carbon in covalent linkage, with a valency of one.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (12)

PathwayProteinsCompounds
Disease1278231
Infectious disease89579
Latent infection of Homo sapiens with Mycobacterium tuberculosis3232
Latent infection - Other responses of Mtb to phagocytosis3233
Tolerance by Mtb to nitric oxide produced by macrophages1121
Immune System91482
Innate Immune System41475
ROS and RNS production in phagocytes1237
Infection with Mycobacterium tuberculosis7442
Bacterial Infection Pathways12347
Focal adhesion: PI3K-Akt-mTOR signaling pathway02
Focal adhesion: PI3K-Akt-mTOR-signaling pathway02

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (5.88)18.7374
1990's0 (0.00)18.2507
2000's5 (29.41)29.6817
2010's9 (52.94)24.3611
2020's2 (11.76)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 59.14

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index59.14 (24.57)
Research Supply Index2.94 (2.92)
Research Growth Index4.61 (4.65)
Search Engine Demand Index94.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (59.14)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]